Copyright
        ©The Author(s) 2020.
    
    
        World J Gastroenterol. Sep 28, 2020; 26(36): 5463-5473
Published online Sep 28, 2020. doi: 10.3748/wjg.v26.i36.5463
Published online Sep 28, 2020. doi: 10.3748/wjg.v26.i36.5463
		Figure 1 Antithrombotic classes according to gastro-intestinal bleeding lesion location.
		
			 Overall chi-square test P value = 0.03. All pair-wise comparisons with Bonferroni correction > 0.10 except for direct oral anticoagulant compared to AP (P value = 0.02). AP: Antiplatelet agent; DOAC: Direct oral anticoagulant; GI: Gastrointestinal; VKA: Vitamin K antagonist.
		
	
		Figure 2 Antithrombotic classes according to gastro-duodenal ulcer and proton pump inhibitor use.
		
			 General association statistic P value = 0.05. AP: Antiplatelet agent; DOAC: Direct oral anticoagulant; VKA: Vitamin K antagonist.
		
	
		Figure 3 Antithrombotic classes according to gastro-intestinal bleeding type and in-hospital mortality.
		
			 General association statistic P value = 0.09. AP: Antiplatelet agent; DOAC: Direct oral anticoagulant; VKA: Vitamin K antagonist.
		
	
- Citation: Bouget J, Viglino D, Yvetot Q, Oger E. Major gastrointestinal bleeding and antithrombotics: Characteristics and management. World J Gastroenterol 2020; 26(36): 5463-5473
- URL: https://www.wjgnet.com/1007-9327/full/v26/i36/5463.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i36.5463

 
         
                         
                 
                 
                 
                 
                 
                         
                         
                         
                         
			 
			